Physician profile
Tamara Marie Tobias
NPI 1568597813
$30,211.19
in general payments reported to CMS, 2019-2025
4 companies · $4,707 in 2025
The $4,707 reported for 2025 was more than what 99% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,469 · 2022: $4,520 · 2023: $5,430 · 2024: $12K · 2025: $4,707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,870 · Travel and Lodging: $6,006 · Consulting Fee: $3,794 · Food and Beverage: $2,450 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,870.00 |
| Travel and Lodging | $6,005.98 |
| Consulting Fee | $3,794.04 |
| Food and Beverage | $2,450.15 |
| Education | $101.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $29,108.72 | 2021-2025 | Menopur, Adstiladrin |
| Emd Serono, INC. | $768.31 | 2021-2025 | |
| Organon LLC | $184.38 | 2022-2025 | Follistim Aq, Pregnyl, Ganirelix Acetate |
| Myovant Sciences INC. | $149.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Tobias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.